40% Of Drugs Affected By Price Cuts Fall Below State Contract Prices
This article was originally published in PharmAsia News
Executive Summary
Following China’s 28th round of mandatory drug price cuts on March 30, prices of 43% of affected drugs that saw their prices fall below their state procurement prices awarded.